| Literature DB >> 27272565 |
Lakshmi Krishnamoorthy1,2, Joseph A Cotruvo1, Jefferson Chan1, Harini Kaluarachchi1, Abigael Muchenditsi3, Venkata S Pendyala3, Shang Jia1, Allegra T Aron1, Cheri M Ackerman1, Mark N Vander Wal1, Timothy Guan1, Lukas P Smaga1, Samouil L Farhi1, Elizabeth J New1, Svetlana Lutsenko3, Christopher J Chang1,2,4,5.
Abstract
Cell signaling relies extensively on dynamic pools of redox-inactive metal ions such as sodium, potassium, calcium and zinc, but their redox-active transition metal counterparts such as copper and iron have been studied primarily as static enzyme cofactors. Here we report that copper is an endogenous regulator of lipolysis, the breakdown of fat, which is an essential process in maintaining body weight and energy stores. Using a mouse model of genetic copper misregulation, in combination with pharmacological alterations in copper status and imaging studies in a 3T3-L1 white adipocyte model, we found that copper regulates lipolysis at the level of the second messenger, cyclic AMP (cAMP), by altering the activity of the cAMP-degrading phosphodiesterase PDE3B. Biochemical studies of the copper-PDE3B interaction establish copper-dependent inhibition of enzyme activity and identify a key conserved cysteine residue in a PDE3-specific loop that is essential for the observed copper-dependent lipolytic phenotype.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27272565 PMCID: PMC4955676 DOI: 10.1038/nchembio.2098
Source DB: PubMed Journal: Nat Chem Biol ISSN: 1552-4450 Impact factor: 15.040